The Global Lung Cancer Therapeutics Market to Contribute Around $11.19 Billion By 2020
ResearchMoz presents professional and in-depth study of "Global Lung Cancer Therapeutics Market 2016-2020". Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly. Technavios analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also considers the r...